Arcus Biosciences, Inc. (RCUS)
24.44
-0.79
(-3.13%)
USD |
NYSE |
Oct 02, 16:00
24.06
-0.38
(-1.55%)
Pre-Market: 20:00
Arcus Biosciences Total Return Level : 24.44 for Oct. 2, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 02, 2026 | 24.44 |
| October 01, 2026 | 25.23 |
| September 30, 2026 | 25.83 |
| September 29, 2026 | 25.65 |
| September 28, 2026 | 25.01 |
| September 25, 2026 | 24.97 |
| September 24, 2026 | 25.06 |
| September 23, 2026 | 26.39 |
| September 22, 2026 | 26.87 |
| September 21, 2026 | 25.95 |
| September 18, 2026 | 25.24 |
| September 17, 2026 | 25.54 |
| September 16, 2026 | 24.65 |
| September 15, 2026 | 24.32 |
| September 14, 2026 | 24.07 |
| September 11, 2026 | 24.59 |
| September 10, 2026 | 26.15 |
| September 09, 2026 | 28.49 |
| September 08, 2026 | 29.06 |
| September 04, 2026 | 29.66 |
| September 03, 2026 | 30.13 |
| September 02, 2026 | 29.85 |
| September 01, 2026 | 29.71 |
| August 31, 2026 | 29.28 |
| August 28, 2026 | 29.21 |
| Date | Value |
|---|---|
| August 27, 2026 | 30.59 |
| August 26, 2026 | 30.76 |
| August 25, 2026 | 31.57 |
| August 24, 2026 | 30.12 |
| August 21, 2026 | 30.34 |
| August 20, 2026 | 29.52 |
| August 19, 2026 | 30.35 |
| August 18, 2026 | 29.51 |
| August 17, 2026 | 29.56 |
| August 14, 2026 | 29.48 |
| August 13, 2026 | 28.86 |
| August 12, 2026 | 28.96 |
| August 11, 2026 | 28.74 |
| August 10, 2026 | 28.72 |
| August 07, 2026 | 28.62 |
| August 06, 2026 | 28.33 |
| August 05, 2026 | 27.70 |
| August 04, 2026 | 28.80 |
| August 03, 2026 | 27.62 |
| July 31, 2026 | 28.19 |
| July 30, 2026 | 28.25 |
| July 29, 2026 | 26.45 |
| July 28, 2026 | 27.05 |
| July 27, 2026 | 27.84 |
| July 24, 2026 | 28.42 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Halozyme Therapeutics, Inc. | 109.86 |
| AVITA Medical, Inc. | 12.72 |
| Iovance Biotherapeutics, Inc. | 14.22 |
| Editas Medicine, Inc. | 2.62 |
| Recursion Pharmaceuticals, Inc. | 4.12 |